Search

Your search keyword '"Leppert, John T."' showing total 148 results

Search Constraints

Start Over You searched for: Author "Leppert, John T." Remove constraint Author: "Leppert, John T." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
148 results on '"Leppert, John T."'

Search Results

1. Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer.

2. Associations of Renal Cell Carcinoma Subtype with Patient Demographics, Comorbidities, and Neighborhood Socioeconomic Status in the California Population.

4. Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study

7. Recurrent repeat expansions in human cancer genomes

13. Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest

14. Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies

17. Ambient air pollution and urological cancer risk: A systematic review and meta-analysis of epidemiological evidence.

23. Groundwater constituents and the incidence of kidney cancer

24. Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism

25. MP64-01 GROUNDWATER CONSTITUENTS AND THE INCIDENCE OF KIDNEY CANCER

27. MP63-02 PROSPECTIVE MULTI-INSTITUTIONAL VALIDATION OF a 3-GENE mRNA BIOMARKER PANEL FOR DETECTION AND SURVEILLANCE OF NON-MUSCLE INVASIVE BLADDER CANCER

28. Data from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma

29. Figure S5 from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma

30. Supplementary Tables from S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma

31. Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning framework

32. Recurrent repeat expansions in human cancer genomes

35. Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low‐ and very‐low risk prostate cancer

36. A genome-wide atlas of recurrent repeat expansions in human cancer

38. Unpacking low-value castration practices using behavior specification to guide de-implementation in prostate cancer care.

46. Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration

48. Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS)

49. Kidney Stone Events Following Parathyroidectomy vs Nonoperative Management for Primary Hyperparathyroidism.

50. Interaction between race and prostate cancer treatment benefit in the Veterans Health Administration.

Catalog

Books, media, physical & digital resources